Could a common pain drug boost spinal cord healing?
NCT ID NCT05302999
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study is checking if it's possible to give gabapentin, a nerve pain medication, within the first few days after a spinal cord injury. The goal is to see if a larger study on nerve recovery can be done. About 42 adults with any level or severity of spinal cord injury will take either gabapentin or a placebo. The main focus is on whether people can be recruited and stick with the treatment, not yet on whether the drug works.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MetroHealth Medical Center
RECRUITINGCleveland, Ohio, 44109, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could music be medicine for the injured brain?
- Robots join the rehab team: a new hope for regaining movement?
- Can a sugar pill curb the opioid crisis?
- Testosterone may rebuild strength after spinal cord injury โ trial puts it to the test
- Can a smart brain implant outsmart chronic pain?
- Can a new rowing seat help veterans with paralysis row freely?